Search is Powered by Google
Depression News

The Yin And Yang Of Genes For Mood Disorders

Main Category: Depression
Also Included In: Genetics;  Psychology / Psychiatry
Article Date: 13 Mar 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (6 votes)

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

Individual genes do not cause depression, but they are thought to increase the probability of an individual having a depression in the face of other accumulating risk factors, such as other genes and environmental stressors. One gene that has been shown to increase the risk for depression in the context of multiple stressful life events is the gene for the serotonin transporter protein. This gene is responsible for making the protein that is targeted by all current drug treatments for depression. In a number of studies it has been shown that people who inherit one form of this gene, called SLC6A4, are at up to four times the risk of depression if they experience unusual stresses in their lives. Basic science experiments and imaging studies in normal people suggest that the way this form of the gene affects risk for depression is by impacting on the development of a system in the brain that mediates how negative environmental stresses and threats feel. The effects of this serotonin gene on this brain system are thought to occur early in development, where the shaping of brain systems related to how the environment is experienced emotionally is critically determined.

Basic science experiments have shown that another gene, called BDNF, regulates the expression of a protein that is important for the ability of the serotonin gene to cause these developmental effects. The BNDF gene plays a critical role in allowing the serotonin gene to have its affect on brain development. Interestingly, the BDNF gene also has been found to be a risk factor for mood disorders and is thought to be important in mediating the effects of antidepressant drugs. Thus, given the basic molecular link between SLC56A4 and BDNF, and the potential that risk for depression might be better understood in the context of these two genes together rather than any one of them alone, investigators now have looked at how inheriting different combinations of forms of these two gene would impact on the development of this emotion regulation system in the brain. They found that in normal subjects the deleterious impact of the serotonin gene on the development of this brain system was critically dependent on which form of the BDNF gene was also inherited. If an individual inherited one form of the BDNF gene, they were particularly susceptible to the deleterious form of the serotonin gene but if they inherited the other form of the BDNF gene, they were completely protected against it.

This study is the first to show the complex interactions that occur between mood disorder related genes and their impact on mood disorder related brain circuitry. The study makes it clear that individual genes have to be viewed in a context, both a genetic and an environmental context. But the results also illustrate that no one gene is an island unto itself, and the impact that any gene will have on complex condition like mental illnesses will depend on how that gene interacts with other genes sharing biological overlap. This study also makes it clear why individuals genes do not show stronger effects on predicting complex illnesss like depression, because risk is based on the combinatorial effects of interacting risk factors.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Citation source: Molecular Psychiatry advance online publication 12 MARCH 2008 - 5:00 PM EST.

For further information on this article, please contact the Corresponding Author:

Daniel R. Weinberger, M.D.
Director: Genes, Cognition and Psychosis Program
IRP, NIMH,NIH
Rm. 4S-235
10 Center Drive
Bethesda, Md. 20892, USA
web: http://cbdb.nimh.nih.gov/

Molecular Psychiatry is a peer-reviewed independent journal that publishes groundbreaking research in psychiatry and related fields. The journal's Impact Factor is 11.804, 2nd of 95 in Psychiatry
Website: http://www.nature.com/mp
Editor: Julio Licinio, M.D.
University of Miami Miller School of Medicine

Source: Daniel R. Weinberger, M.D.
Molecular Psychiatry




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader




Treating Major Depression image Treating Major Depression

Major depression is more than just suffering from a bad mood. It can affect just about everything you do, from how you sleep at night to how well you perform your job. Learn how you can feel better...

What Is Depression? image What Is Depression?

How do you know if your bad mood represents something more serious? Learn how to recognize the various types of depression, and what you can do to get professional help...

View more videos...

Add Your Advertisement Here